Test potential kidney donors of African ancestry for APOL1 risk variants to determine kidney disease risk status. Get results within 7 days of receipt for potential live donors and patients at risk.
Rapid APOL1 genetic testing services are based on the research of Barry I. Freedman, MD, John H. Felts, III Professor and Chief of Nephrology at Wake Forest. Freedman is an active clinician-researcher whose research focuses on genetic causes of kidney and cardiovascular disease, hypertension and type 2 diabetes, particularly in African-Americans; as well as clinical outcomes in chronic kidney disease and after renal transplantation.
Learn more about Dr. Freedman and Wake Forest's Division of Nephrology
Learn more about the HLA/Immunogenetics Laboratory